Congenital alpha(2)-plasmin inhibitor deficiencies: a review.
Favier
R
R
Service d'Hématologie Biologique, Hôpital Armand Trousseau, Paris, France.
Aoki
N
N
de Moerloose
P
P
D000614:Aminocaproates / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D005342:Fibrinolysis; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D010949:Plasma; D014148:Tranexamic Acid / Q000627:therapeutic use; D000979:alpha-2-Antiplasmin / Q000737:chemistry / Q000172:deficiency*
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D000979:alpha-2-Antiplasmin; D014148:Tranexamic Acid